日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lipids regulate epidermal growth factor receptor activation by its ligands

脂质通过其配体调节表皮生长因子受体的激活

Hutchison, James M; Lemmon, Mark A

The role of kinase domain dimerization in EGFR activation.

激酶结构域二聚化在 EGFR 激活中的作用。

Petrova Zaritza O, Han Long, Tsutsui Yuko, Sheetz Joshua B, Ashtekar Kumar D, Lemmon Mark A

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

奥希替尼治疗携带罕见EGFR 19号外显子缺失突变的肺癌患者的疗效

Grant, Michael J; Aredo, Jacqueline V; Starrett, Jacqueline H; Stockhammer, Paul; van Alderwerelt van Rosenburgh, Iris K; Wurtz, Anna; Piper-Valillo, Andrew J; Piotrowska, Zofia; Falcon, Christina; Yu, Helena A; Aggarwal, Charu; Scholes, Dylan; Patil, Tejas; Nguyen, Christina; Phadke, Manali; Li, Fang-Yong; Neal, Joel; Lemmon, Mark A; Walther, Zenta; Politi, Katerina; Goldberg, Sarah B

Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers

攻克“不可成药”的MYCN致癌转录因子:克服以往障碍,影响儿童癌症治疗

Wolpaw, Adam J; Bayliss, Richard; Büchel, Gabriele; Dang, Chi V; Eilers, Martin; Gustafson, W Clay; Hansen, Gwenn H; Jura, Natalia; Knapp, Stefan; Lemmon, Mark A; Levens, David; Maris, John M; Marmorstein, Ronen; Metallo, Steven J; Park, Julie R; Penn, Linda Z; Rape, Michael; Roussel, Martine F; Shokat, Kevan M; Tansey, William P; Verba, Kliment A; Vos, Seychelle M; Weiss, William A; Wolf, Elmar; Mossé, Yaël P

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations

一线奥希替尼耐药EGFR突变的药物敏感性和等位基因特异性

Starrett, Jacqueline H; Guernet, Alexis A; Cuomo, Maria Emanuela; Poels, Kamrine E; van Alderwerelt van Rosenburgh, Iris K; Nagelberg, Amy; Farnsworth, Dylan; Price, Kristin S; Khan, Hina; Ashtekar, Kumar Dilip; Gaefele, Mmaserame; Ayeni, Deborah; Stewart, Tyler F; Kuhlmann, Alexandra; Kaech, Susan M; Unni, Arun M; Homer, Robert; Lockwood, William W; Michor, Franziska; Goldberg, Sarah B; Lemmon, Mark A; Smith, Paul D; Cross, Darren A E; Politi, Katerina

Insulin and epidermal growth factor receptor family members share parallel activation mechanisms

胰岛素和表皮生长因子受体家族成员具有相似的激活机制。

Ferguson, Kathryn M; Hu, Chun; Lemmon, Mark A

Occupy EGFR

占据 EGFR

Park, Jin H; Lemmon, Mark A

Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family

评估胰岛素受体家族中激酶自身抑制机制的范围

Artim, Stephen C; Mendrola, Jeannine M; Lemmon, Mark A

Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain

厄洛替尼可与 EGFR 酪氨酸激酶结构域的非活性构象和活性构象均结合。

Park, Jin H; Liu, Yingting; Lemmon, Mark A; Radhakrishnan, Ravi

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

神经母细胞瘤中发现的间变性淋巴瘤激酶变体的抑制剂敏感性差异

Bresler Scott C, Wood Andrew C, Haglund Elizabeth A, Courtright Joshua, Belcastro Lili T, Plegaria Jefferson S, Cole Kristina, Toporovskaya Yana, Zhao Huaqing, Carpenter Erica L, Christensen James G, Maris John M, Lemmon Mark A, Mossé Yaël P